Elevance Health Inc. (NYSE:ELV) reported strong Q2 results and raised full-year guidance. Analysts have adjusted price targets for ELV stock.

Elevance Health reported second quarter net income of $1.45 billion as medical costs fell in some health plans, triggering an improved outlook for the rest of the year.

Elevance Health is kicking off another round of quarterly earnings results for major insurers, posting $1.5 billion in profit for Q2. | Elevance Health is kicking off another…